Document:

exv10w1

Exhibit 10.1

AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT

          This Amendment No. 1 to Loan and Security Agreement (this “Amendment”) is made as of March 12,
2009, by and among COMMERCIAL VEHICLE GROUP, INC., a Delaware corporation (the “Company”), each
other Borrower, as defined in the Loan Agreement referred to below (together with the Company,
collectively, “Borrowers”), the financial institutions party to the Loan Agreement as lenders
(collectively, “Lenders”), and BANK OF AMERICA, N.A., as agent for Lenders (“Agent”).

RECITALS:

          A. Borrowers, Agent and Lenders are parties to that certain Loan and Security Agreement, dated
as of January 7, 2009 (as may be further amended, restated, supplemented or otherwise modified from
time to time, the “Loan Agreement”).

          B. Borrowers, Agent and Lenders desire to amend the Loan Agreement as more fully set forth
herein.

          C. Each capitalized term used herein and not otherwise defined herein shall have the same
meaning set forth in the Loan Agreement.

AGREEMENT:

          In consideration of the premises and mutual covenants herein and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, Borrowers, Agent and
Lenders agree as follows:

     1. Amended and Restated Definitions. Section 1.1 of the Loan Agreement is hereby amended to
amend and restate the definitions of “Applicable Margin”, “EBITDA”, and “Margin Reduction” in their
entirety as follows:

          “Applicable Margin: with respect to any Type of Loan, subject in each case to the Margin
Reduction, if applicable, (i) 5.00% for LIBOR Revolver Loans and (ii) 4.00% for Domestic Base Rate
Loans.”

          “EBITDA: determined on a consolidated basis for Borrowers and Subsidiaries, the sum of (i) net
income, calculated before (a) interest expense, (b) provision for income taxes, (c) depreciation
and amortization expense, (d) gains or losses arising from the sale of capital assets, (e) gains
arising from the write-up of assets, (f) any extraordinary gains, (g) non-cash charges and expenses
(other than those which represent a reserve for or actual cash item in such period or any future
period), (h) one-time non-recurring costs and expenses associated with the issuance of Equity
Interests, to the extent such costs and expenses are financed with the proceeds of such issuance,
(i) costs and expenses in connection with the termination of the Obligors’ existing credit facility
and the execution of the Loan Documents, (j) severance costs and expenses to the extent paid in
cash (regardless of when actually paid) in an amount not to exceed (1) $1,500,000 in the aggregate
for the Fiscal Year ending December 31, 2009 (but in any event not to exceed $500,000 in the
aggregate in any Fiscal Quarter, or $250,000 in the aggregate in any Fiscal Month, of the Fiscal
Year ending December 31, 2009) and (2) $1,000,000 in the aggregate in any Fiscal Year thereafter,
and (k) any non-cash losses resulting from mark to market accounting of Hedging Agreements (in each
case, to the extent included in determining net income) minus (ii) non-cash gains (including those
resulting from mark to market accounting of Hedging Agreements) minus (iii) cash

 

payments made in such period to the extent such payments relate to a non-cash loss, charge or
expense in any prior period which was added back in determining EBITDA.”

          “Margin Reduction: a reduction in the otherwise applicable Applicable Margin equal to
0.25%, applicable if, at the end of any Fiscal Quarter ending on or after March 31, 2010, (i)
average Domestic Availability for each day during such Fiscal Quarter was greater than $20,000,000
and (ii) the Fixed Charge Coverage Ratio shall be at least 1.0 to 1.0; provided that such reduction
shall be effective on the first day of the calendar month following receipt by Agent of
certification by Borrower Agent of the average Domestic Availability during such Fiscal Quarter.”

     2. Amendment to Section 10.3.2. Section 10.3.2. of the Loan Agreement is hereby
amended and restated in its entirety as follows:

          “10.3.2. Capital Expenditures. Not permit the aggregate amount of Capital Expenditures
made by Borrowers and their Subsidiaries to exceed (i) $4,300,000 in the aggregate from January 1,
2009 through June 30, 2009 and (ii) $9,700,000 in the aggregate for the Fiscal Year ending December
31, 2009.”

     3. Amendment to Section 10.3.3. Section 10.3.3. of the Loan Agreement is hereby
amended and restated in its entirety as follows:

          “10.3.3. EBITDA. Maintain cumulative EBITDA for the periods specified below as of the
end of each Fiscal Month specified below, at least equal to the following amounts:

	 	 	 	 	 
	Period Ending On or Around	 	EBITDA
	April 1, 2009 through April 30, 2009
	 	$	(3,250,000	)
	April 1, 2009 through May 31, 2009
	 	$	(3,530,000	)
	April 1, 2009 through June 30, 2009
	 	$	(1,750,000	)
	April 1, 2009 through July 31, 2009
	 	$	1,200,000	 
	April 1, 2009 through August 30, 2009
	 	$	3,600,000	 
	April 1, 2009 through September 30, 2009
	 	$	9,200,000	 
	April 1, 2009 through October 31, 2009
	 	$	13,200,000	 
	April 1, 2009 through November 30, 2009
	 	$	17,600,000	 
	April 1, 2009 through December 31, 2009
	 	$	22,000,000	 

     4. Amendment to Section 10.3.4. Section 10.3.4 of the Loan Agreement is hereby amended
and restated in its entirety as follows:

          “10.3.4. Domestic Availability. Maintain Domestic Availability of at least $11,500,000
at all times; provided, however, that if Borrowers deliver a Compliance Certificate
pursuant to Section

2

 

10.1.2(c) for any Fiscal Quarter ending March 31, 2010 or thereafter demonstrating that Borrowers’
Fixed Charge Coverage Ratio is at least 1.0 to 1.0 as of the end of such Fiscal Quarter, Borrowers
shall be required to maintain Domestic Availability of at least $7,500,000 at all times
thereafter.”

     5. Conditions Precedent. This Amendment shall become effective on the date that the
following conditions are satisfied or waived:

     (a) this Amendment has been executed by each Domestic Borrower, Agent and Lenders, and
counterparts hereof as so executed shall have been delivered to Agent;

     (b) Borrowers have paid all reasonable out-of-pocket fees and expenses of Agent and of
legal counsel to Agent that have been invoiced on or prior to such date in connection with
the preparation, negotiation, execution and delivery of this Amendment;

     (c) all representations and warranties of each Obligor contained in the Loan Agreement
or in the other Loan Documents shall be true and correct in all material respects with the
same effect as though such representations and warranties had been made on and as of the
date of this Amendment, except to the extent that such representations and warranties
expressly relate to an earlier specified date, in which case such representations and
warranties shall have been true and correct in all material respects as of the date when
made;

     (d) the Company shall have delivered to Agent the amendment to the Fee Letter, dated as
of the date hereof, and shall have paid to Agent all fees set forth therein.

     6. Representations and Warranties. Each Domestic Borrower hereby represents and
warrants to Agent and Lenders that: (a) Each Domestic Borrower is duly authorized to execute,
deliver and perform its obligations under this Amendment; (b) the execution, delivery and
performance of this Amendment has been duly authorized by all necessary action, and does not (i)
require any consent or approval of any holders of Equity Interests of any Domestic Borrowers, other
than those already obtained, (ii) contravene the Organic Documents of any Domestic Borrower, (iii)
violate or cause a default under any Applicable Law, Material Contract or Restrictive Agreement
except to the extent such violation or default could not reasonably be expected to result in a
Material Adverse Effect, or (iv) result in or require the imposition of any Lien (other than
Permitted Liens) on any Property of any Domestic Borrower; (c) no Default or Event of Default
exists under the Loan Agreement, nor will any occur immediately after the execution and delivery of
this Amendment or by the performance or observance of any provision hereof; and (d) this Amendment
constitutes a valid and binding obligation of such Borrower in every respect, enforceable in
accordance with its terms except as enforceability may be limited by bankruptcy, insolvency or
similar laws affecting the enforcement of creditors’ rights generally.

     7. Loan Agreement Unaffected. Each reference that is made in the Loan Agreement or any
other Loan Document shall hereafter be construed as a reference to the Loan Agreement as amended
hereby. Except as herein otherwise specifically provided, all provisions of the Loan Agreement
shall remain in full force and effect and be unaffected hereby.

     8. Counterparts. This Amendment may be executed in any number of counterparts, by
different parties hereto in separate counterparts, each of which when so executed and delivered
shall be deemed to be an original and all of which taken together shall constitute but one and the
same agreement. Delivery of a signature page of this Amendment by telecopy or other electronic
means shall be effective as delivery of a manually executed counterpart of such agreement.

3

 

     9. Entire Agreement. This Amendment is specifically limited to the matters expressly
set forth herein. This Amendment and all other instruments, agreements and documents executed and
delivered in connection with this Amendment embody the final, entire agreement among the parties
hereto with respect to the subject matter hereof and supersede any and all prior commitments,
agreements, representations and understandings, whether written or oral, relating to the matters
covered by this Amendment, and may not be contradicted or varied by evidence of prior,
contemporaneous or subsequent oral agreements or discussions of the parties hereto. There are no
oral agreements among the parties hereto relating to the subject matter hereof or any other subject
matter relating to the Loan Agreement.

     10. Governing Law; Submission to Jurisdiction; Venue; Waiver of Jury Trial.

     (a) THIS AMENDMENT SHALL BE GOVERNED BY THE LAWS OF THE STATE OF ILLINOIS, WITHOUT GIVING
EFFECT TO ANY CONFLICT OF LAW PRINCIPLES (BUT GIVING EFFECT TO FEDERAL LAWS RELATING TO NATIONAL
BANKS).

     (b) EACH PARTY HERETO HEREBY CONSENTS TO THE NON-EXCLUSIVE JURISDICTION OF ANY FEDERAL OR
STATE COURT SITTING IN OR WITH JURISDICTION OVER ILLINOIS, IN ANY PROCEEDING OR DISPUTE RELATING IN
ANY WAY TO THIS AMENDMENT AND AGREES THAT ANY SUCH PROCEEDING SHALL BE BROUGHT BY IT SOLELY IN ANY
SUCH COURT. EACH PARTY HERETO IRREVOCABLY WAIVES ALL CLAIMS, OBJECTIONS AND DEFENSES THAT IT MAY
HAVE REGARDING SUCH COURT’S PERSONAL OR SUBJECT MATTER JURISDICTION, VENUE OR INCONVENIENT FORUM.
EACH PARTY HERETO IRREVOCABLY CONSENTS TO SERVICE OF PROCESS IN THE MANNER PROVIDED FOR NOTICES IN
SECTION 14.3.1 OF THE LOAN AGREEMENT. Nothing herein shall limit the right of Agent or any Lender
to bring proceedings against any Obligor in any other court, nor limit the right of any party to
serve process in any other manner permitted by Applicable Law. Nothing in this Amendment shall be
deemed to preclude enforcement by Agent of any judgment or order obtained in any forum or
jurisdiction.

     (c) Borrowers hereby irrevocably waive any objection that they may now or hereafter have to
the laying of venue of any of the aforesaid actions or proceedings arising out of or in connection
with this Amendment brought in the courts referred to in Section 10(a) and (b) above and hereby
further irrevocably waive and agree not to plead or claim in any such court that any such action or
proceeding brought in any such court has been brought in an inconvenient forum.

     (d) To the fullest extent permitted by Applicable Law, each Borrower waives the right to trial
by jury (which Agent and each Lender hereby also waives) in any proceeding or dispute of any kind
relating in any way to this Amendment or the transactions contemplated thereby. Each Borrower
acknowledges that the foregoing waivers are a material inducement to Agent and Lenders entering
into this Amendment and that Agent and Lenders are relying upon the foregoing in their dealings
with Borrowers.

(Signature pages follow.)

4

 

          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date first
above written.

	 	 	 	 	 	 	 
	 	 	BORROWERS:	 	 
	 
	 	 	 	 	 	 
	 	 	COMMERCIAL VEHICLE GROUP, INC.	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Chad M. Utrup
 

Chad M. Utrup
	 	 
	 

	 	Title:
	 	Chief Financial Officer	 	 
	 
	 	 	 	 	 	 
	 	 	NATIONAL SEATING COMPANY

CVG CS LLC

MONONA CORPORATION MONONA WIRE

CORPORATION MONONA (MEXICO) HOLDINGS LLC

TRIM SYSTEMS, INC.

TRIM SYSTEMS OPERATING CORP.

CABARRUS PLASTICS, INC.

CVG OREGON, LLC 

CVS HOLDINGS, INC.

SPRAGUE DEVICES, INC.

MAYFLOWER VEHICLE SYSTEMS, LLC

CVG MANAGEMENT CORPORATION 

CVG EUROPEAN HOLDINGS, LLC

CVG LOGISTICS, LLC	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Chad M. Utrup
 

Chad M. Utrup
	 	 
	 

	 	Title:
	 	Chief Financial Officer	 	 

 

	 	 	 	 	 	 	 
	 	 	BANK OF AMERICA, N.A., as Agent and as a

Lender	 	 
	 
	 	 	 	 	 	 
	 

	 	By:

Name:
	 	/s/ Philip Nomura
 

Philip Nomura
	 	 
	 

	 	Title:
	 	Vice PresidentEX-10.11

Exhibit 10.11

STOCK APPRECIATION RIGHT GRANT NOTICE AND AGREEMENT

          MedAssets, Inc. (the “Company”), pursuant to its Long Term Performance Incentive Plan
(the “Plan”), hereby grants to Holder the number of Stock Appreciation Rights (each, a
“SAR,” and together, the “SARs”) set forth below, pursuant the terms of this Stock
Appreciation Right Grant Notice and Agreement (this “Grant Notice”). The SARs are subject
to all of the terms and conditions set forth herein as well as all of the terms and conditions of
the Plan, all of which are incorporated herein in their entirety. Capitalized terms not otherwise
defined herein shall have the same meaning as set forth in the Plan.

	 	 	 
	Holder:

	 	 
	 
	Date of Grant:

	 	 
	 
	Number of Stock Appreciation
	 	 
	Rights:

	 	 
	 
	Base Price:

	 	 
	 
	Expiration Date:

	 	 

	 	 	 
	Vesting
Schedule:

Exercise of SARs:

	 	[Applicable vesting schedule to be inserted]

Subject to any subsequent procedures that the Company may implement relating to the
exercise of vested SARs, to exercise vested SARs, Holder (or his or her authorized
representative) must give written notice to the Company, using the form of Stock
Appreciation Right Exercise Notice attached hereto as Exhibit A, stating the number
of SARs which he or she intends to exercise.
	 
	 	 
	 

	 	Upon exercise of SARs, Holder will be required to satisfy applicable withholding
tax obligations as provided in Section 14 of the Plan.
	 
	 	 
	Settlement of SARs:

	 	Following the proper exercise of vested SARs by Holder, the Company will settle the
SARs by issuing to Holder the number of shares of Stock, rounded down to the
nearest whole number of shares, equal to (i) the number of SARs being exercised
multiplied by (ii) a fraction, the numerator of which equals the positive
difference, if any, between the Fair Market Value of a share of Stock on the
exercise date less the Base Price, and the denominator of which equals the Fair
Market Value of a share of Stock on the exercise date.
	 
	 	 
	Termination:

	 	In the event of Holder’s Termination prior to the Expiration Date for any reason
other than (i) by the Employer for Cause, (ii) by reason of Holder’s death or
Disability, or (iii) by reason of a Qualifying Retirement, (A) all vesting with
respect to the SARs shall cease, (B) any unvested SARs shall expire as of the date
of such Termination, and (C) any vested SARs shall remain exercisable until the
earlier of the Expiration Date or the date that is ninety (90) days after the date
of such Termination.
	 
	 	 
	 

	 	In the event of Holder’s Termination with the Employer prior to the Expiration Date
by reason of such Holder’s death or Disability, (i) all vesting with respect to the
SARs shall cease, (ii) any unvested SARs shall expire as of the date of such
Termination, and (iii) any vested SARs shall expire on the earlier of the
Expiration Date or the date that is twelve (12) months after the date of such
Termination due to death or Disability of Holder. In the event of Holder’s death,
the SARs shall remain exercisable by the person or persons to whom Holder’s rights
under the SARs pass by will or the applicable laws of descent and distribution
until its expiration, but only to the extent the SARs were vested by such Holder at
the time of such Termination due to death.
	 
	 	 
	 

	 	In the event of Holder’s Termination prior to the Expiration Date by reason of a
Qualifying Retirement, (i) the SARs shall continue to vest in accordance with their
original vesting schedule as if no such termination had occurred, and (ii) the SARs
shall remain exercisable until the Expiration Date.
	 
	 	 
	 

	 	In the event of Holder’s Termination prior to the Expiration Date by the Employer
for Cause, all SARs (whether or not vested) shall immediately expire as of the date
of such termination.
	 
	 	 
	Additional Terms:
	 	 

1

 

	 	•	 	SARs shall be exercisable in whole shares of Stock only.
	 
	 	•	 	Holder acknowledges and agrees that, as a condition of the grant
of SARs hereunder, and in accordance with Section 18(a) of the Plan,
the SARs granted hereunder (and any Stock acquired upon the
settlement of such SARs) will be forfeited, in the discretion of the
Committee, in the event that (i) at any time during the term of
Holder’s employment with the Company, or prior to the second (2nd)
anniversary of Holder’s Termination for any reason, the Committee in
good faith determines that Holder has committed a material breach of
Holder’s employment or post-employment obligations to the Company,
or (ii) any forfeiture event set forth in any incentive compensation
clawback or recoupment policy then approved by the Company occurs.
Holder further acknowledges and agrees that the adoption or
amendment of any such policy shall in no event require the prior
consent of Holder.
	 
	 	•	 	This Grant Notice does not confer upon Holder any right to
continue as a service provider of the Company, the Employer or any
of their respective Affiliates.
	 
	 	•	 	This Grant Notice shall be construed and interpreted in
accordance with the laws of the State of Delaware, without regard to
the principles of conflicts of law thereof.
	 
	 	•	 	Holder agrees that the Company may deliver by email all documents
relating to the Plan or these SARs (including, without limitation, a
copy of the Plan) and all other documents that the Company is
required to deliver to its security holders (including, without
limitation, disclosures that may be required by the Securities and
Exchange Commission). Holder also agrees that the Company may
deliver these documents by posting them on a website maintained by
the Company or by a third party under contract with the Company. If
the Company posts these documents on a website, it shall notify
Holder by email or such other reasonable manner as then determined
by the Company.

*      *      *

THE UNDERSIGNED HOLDER ACKNOWLEDGES RECEIPT OF THE PLAN, AND, AS AN EXPRESS CONDITION TO THE GRANT
OF SARs UNDER THIS GRANT NOTICE, AGREES TO BE BOUND BY THE TERMS OF BOTH THE GRANT NOTICE AND THE
PLAN.

	 	 	 	 	 	 	 	 	 	 	 
	MEDASSETS, INC.	 	 	 	HOLDER	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	 	 	 
	 

	 	Signature
	 	 	 	 	 	Signature	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Title:

	 	 	 	 	 	Date:	 	 	 	 
	 

	 	 
	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	Date:
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 	 

2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00155-of-00352.parquet"}]]